Epilepsy’s Impact on Memory and Cognition Over Time

Watch Now

Cognitive deficits and memory problems are common among adults with chronic epilepsy. This webinar discusses the course of cognitive and memory aging in people with chronic epilepsy. The presentation addresses factors which contribute to healthy cognitive and brain aging, as well as what patients can do to help prevent cognitive decline.

This webinar is presented by Dr. Bruce Hermann, PhD, Director of the Charles Matthew Neuropsychology Section at the University of Wisconsin School of Medicine and Public Health. Dr. Hermann is an expert in brain and cognitive aging in people with chronic epilepsy. His research focuses on the impact of epilepsy on brain structure, cognition, and psychiatric status.

Dr. Hermann’s presentation is followed by an interactive Q&A session, where he answers questions such as:

  • Can any measures be taken to prevent or combat the cognitive decline that accompanies getting older with epilepsy?
  • Does research suggest specific therapies to help prevent memory loss associated with epilepsy?
  • Are certain individuals with epilepsy more likely to experience cognitive decline as they age than others?

Anxiety and Depression Associated with Epilepsy

Watch Now

Know someone with epilepsy who is anxious or depressed? They are not alone. One-third of people with epilepsy suffer from some form of psychiatric disorder, of which anxiety and depression are the most common.

This webinar will discuss how anxiety and depression in people with epilepsy negatively impacts quality of life, reduces tolerance of antiepileptic medications, and increases the risk of suicidal ideation and behavior. The presentation will also review how stress effects epileptic seizures and will offer strategies that patients can use to better cope with stress.

Dr. Andres M. Kanner, a leading expert on epilepsy and psychiatric disorders, will present this webinar. Dr. Kanner is Chief of the Epilepsy Division in the Department of Neurology and Director of the International Comprehensive Epilepsy Center in the University of Miami Miller School of Medicine.

During a live Q&A session with Dr. Kanner, you can ask questions, such as:

  • What can I do to lower the stress and anxiety that could potentially trigger seizures?
  • How do I know if my depression is linked to my epilepsy or my medications?
  • Are anxiety and depression symptoms dependent upon factors, such as seizure-type or age of epilepsy onset?

Cannabidiol and Epilepsy: The Real Risks and Benefits

Watch Now

Recently, there has been a great deal of focus on the uses and risks of marijuana in the field of epilepsy. Epidiolex, a treatment of cannabidiol (CBD), gained FDA approval for the treatment of seizures associated with Lennox-Gastaut syndrome and Dravet syndrome, two rare and severe forms of epilepsy. This is the first FDA-approved plant based treatment with greater than 98% CBD.

Unlike THC, one of the other components in marijuana, CBD does not cause the euphoria (the “high”) that comes from THC.

In this webinar, learn why CBD may be an effective treatment for certain types of epilepsy, what risks can be associated with CBD, and what the FDA approval of means for the future of epilepsy research and treatment.

Featured Presenter: Anup D. Patel, MD, is Section Chief of Pediatric Neurology at Nationwide Children’s and Associate Professor of Clinical Pediatrics and Neurology at The Ohio State University College of Medicine.

Plus, get additional research insights from CURE Chief Scientific Officer Dr. Laura Lubbers in this episode of our Seizing Life podcast.

The New Way to Describe Your Seizure Type

Watch Now

Managing epilepsy can be a challenge, but understanding the most up-to-date medical terms can help.

Learn the International League Against Epilepsy’s (ILAE) new ways to organize and describe seizures and epilepsy types. Becoming familiar with this new language can enable you and your doctor to better communicate about your treatment options, triggers to avoid, and what to expect in the future.

The webinar is presented by Dr. Robert S. Fisher, who led the task force responsible for the ILAE’s new classification system.

During a live Q&A session with Dr. Fisher, you can ask questions such as:

  • How can I tell what type of seizures I have?
  • Why don’t we use the terms “grand mal” and “petit mal” seizures anymore?
  • How could these new classifications impact my child’s treatment?